The company said it expects Qdenga to become available in India in the first half of 2027. Read more at straitstimes.com.

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced plans to build a dedicated distributor network to support commercialization of its peptide portfolio across ...

A crypto user lost $999,999 in USDt to an Ethereum phishing scam, as Chainalysis said that onchain fraud topped $14 billion ...

QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts ...

New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...

Recent rains in Central Texas have spiked mosquito activity, with one Austin trap testing positive for West Nile virus, ...

Recent rains in Central Texas have spiked mosquito activity, with one Austin trap testing positive for West Nile virus, ...

NEW DELHI, July 21, 2026 /PRNewswire/ -- Takeda today announced that India's Drug Controller General of India (DCGI) has granted marketing authorization for Takeda's dengue vaccine (TAK-003) for the ...

QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It ...

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved ...

SK pharmteco today announced details of its ongoing strategic manufacturing partnership with Genethon, a France-based pioneering nonprofit research and development organization dedicated to gene ...